Disturbances of the plasma coagulation defects in retinal venous occlusions;Poruchy hemokoagulační kaskády u retiná lních venózních okluzí

Ceska a Slovenska Oftalmologie

Volumn 64, Issue 3, 2008, Pages 108-111

  Rehak M ^a,b   Krcova V ^a   Fric, E ^a   Slavik L ^a   Babkova B ^a   Pracharova Z ^a   Langova K ^a   Rehak J ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b Klinik und Poliklinik fur Augenheilkunde   (Germany)

Author keywords

ACP resistance; Leiden mutation; Retinal venous occlusion; Trombophillia

Indexed keywords

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; RETINA VEIN OCCLUSION;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION;

EID: 44649169119     PISSN: 12119059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Albisinni, R.: Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb. Haemost., 80, 1998: 702-703.
2. Aras, S. Yilmaz, G., Alpas, I. Et al.: Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations. Eur. J. Ophthalmol., 11, 2001: 351-355.
3. Arsene, S., Delahousse, B., Regina, S. et al.: Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Thromb. Haemost., 94, 2005: 101-106.
4. Bertina, R.M., Koelemann, B.P.C., Koster, T. et al.: Mutation in blood coagulations factor V associated with resistance to activated protein C. Nature, 369, 1994: 64-67.
5. Bombeli, T., Basic, A., Fehr, J.: Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am. J. Hematol., 70, 2002: 126-132.
6. Cahill, M.T., Stinnett, S.S., Fekrat, S.: Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am. J. Ophthalmol., 136, 2003: 1136-1150.
7. Cruciani, F., Moramarco, A., Curto, T. et al.: MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion. Clin. Ter., 154, 2003: 299-303
8. Dahlbäck, B., Carlsson, M., Svensson, P.J.: Familiar thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: predilection of a cofactor to activated protein C. Proc. Natl. Acad. Sci. USA., 90, 1993: 1004-1008.
9. Demirci, F.Y.K., Güney, D.B., Akarcay, K. et al.: Prevalence of factor V Leiden in patients with retinal vein occlusion. Acta Ophthalmol. Scand., 77, 1999: 631-633.
10. Dithmar, S., Hansen, L.L., Holz, F.G.: Venöse retinale Verschlüsse. Ophthalmologe, 100, 2003: 561-578.
11. Faude, S., Faude, F., Siegemund, A. et al.: Activated protein C resistance in patients with central retinal vein occlusion in comparison to patients with a history of deep-vein thrombosis and a healthy control group. Ophthalmologe, 96, 1999: 594-599.
12. Gori, A.M., Marcucci, R., Fatini, C. et al.: Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels. Thromb. Haemost. 92, 2004: 54-60.
13. Gottlieb, J.L., Blice, J.P., Mestichelli, B. et al.: Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults. Arch. Ophthalmol., 116, 1998: 577-579.
14. Greiner, K., Hafner, G., Dick, B. et al.: Retinal vascular occlusion and deficiencies in the protein C pathway. Am. J. Ophthalmol., 128, 1999:69-74.
15. Hansen, L., Kristensen, H.L., Bek, T. et al.: Markers of thrombophilia in retinal vein thrombosis. Acta Ophthalmol. Scand., 78, 2000: 523-526.
16. Chak, M., Wallace, G.R., Graham, E.M. et al: Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease. Br. J. Ophthalmol., 85, 2001: 883-886.
17. Janssen, M.C., de Heijer, M., Cruysberg, J.R.M. et al.: Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? Thromb. Haemost., 93, 2005: 1021-1026.
18. Kováčová, M., Pochop, P., Hochová, I. et al.: Přínos hematologického vyšetřeni u pacientů s venózní retinální okluzí. Čes. a slov. Oftal., 63, 2007: 193-198.
19. Kuhli, C., Hattenbach, L.O., Scharrer, I. et al.: High prevalence of resistance to APC in young patients with retinal vein occlusion. Graefe's Arch. Clin. Exp. Ophthalmol., 240, 2002: 163-168.
20. Larsson, J., Hillarp, A., Olafsdottir, E. et al.: Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol. Scand., 77, 1999: 634-637.
21. Larsson, J., Olafsdottir, E., Bauer, B.: Activated protein C resistance in young adults with central retinal vein occlusion. Br. J. Ophthalmol., 80, 1996: 200-202.
22. Larsson, J., Sellman, A., Bauer, B.: Activated protein C resistance in patients with central retinal vein occlusion. Br. J. Ophthalmol., 81, 1997:832-834.
23. Linna, T., Ylikorkala, A., Kontula, K. et al.: Prevalence of factor V Leiden in young adults with retinal vein occlusion. Thromb. Haemost., 77, 1997:214-216.
24. Marcucci, R., Bertini, L., Giusti, B. et al.: Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb. Haemost., 86, 2001: 772-776
25. Marcucci, R., Giusti, B., Berti, I. et al.: Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion. Thromb. Res., 110, 2003: 7-12.
26. Salomon, O., Moisseiev, J., Rosenberg, N. et al.: Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul. Fibrinolysis, 9, 1998: 617-622.
27. Svensson, P.J., Zoller, B., Dahlback, B.: Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls. Thromb. Haemost., 77, 1997: 332-335.
28. Tekeli, O., Gürsel, E., Buyurgan, H.: Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion. Acta Ophthalmol. Scand., 77, 1999: 628-630.
29. The Eye Disease Case-Control Study Group: Risk factors for central retinal vein occlusion. Arch. Ophthalmol., 114, 1996: 545-554.
30. Trossaert, M., Conard, J., Horellou, M.H. et al.: The modified APC resistance test in the presence of factor V deficient plasma can be used in patients without oral anticoagulant. Thromb. Haemost., 75, 1996: 521-522.
31. Weger, M., Renner, W., Steinbrugger, I. et al.: Role of thrombophilic gene polymorphisms in branch retinal vein occlusion. Ophthalmology, 112, 2005: 1910-1915.